The Rabbit Blood-shunt Model for the Study of Acute and Late Sequelae of Subarachnoid Hemorrhage: Technical Aspects
October 2nd, 2014
The experimental intracranial pressure-controlled blood shunt subarachnoid hemorrhage (SAH) model in the rabbit combines the standard procedures — subclavian artery cannulation and transcutaneous cisterna magna puncture, which enables close mimicking of human pathophysiological conditions after SAH. We present step-by-step instructions and discuss key surgical points for successful experimental SAH creation.
Overview
This article presents a method for establishing an intracranial pressure-controlled blood shunt model for acute subarachnoid hemorrhage (SAH) in rabbits. The procedure closely mimics human pathophysiological conditions, providing valuable insights into SAH.
Key Study Components
Area of Science
- Neuroscience
- Experimental Surgery
- Pathophysiology
Background
- Subarachnoid hemorrhage (SAH) is a critical condition that affects cerebral blood flow.
- Understanding the mechanisms of SAH can improve treatment outcomes.
- Animal models are essential for studying SAH and its effects on the brain.
- This study focuses on a rabbit model to simulate human SAH conditions.
Purpose of Study
- To create an examiner-independent ICP controlled blood shunt model for SAH.
- To monitor cerebral blood flow and cardiorespiratory responses during SAH.
- To investigate early brain injury and delayed cerebral vessel responses.
Methods Used
- Cannulation of the subclavian artery.
- Digital subtraction angiography.
- Placement of neuromonitoring probes.
- Connection of a spinal access needle to a shunt for ICP control.
Main Results
- The model allows for independent monitoring of ICP and cerebral blood flow.
- Key surgical points are identified for successful SAH induction.
- The method provides insights into neurovascular responses post-SAH.
- Potential implications for understanding outcomes and mortality in SAH cases.
Conclusions
- This rabbit model effectively simulates human SAH conditions.
- It can be used to explore critical questions in the neurovascular field.
- The methodology enhances the understanding of SAH pathophysiology.
Frequently Asked Questions
Executive Industry Relevance
Reliable animal models that recapitulate both early and delayed sequelae of subarachnoid hemorrhage (SAH) are critical for translational neurovascular research and preclinical target validation. The rabbit blood-shunt model enables examiner-independent, intracranial pressure (ICP)-controlled induction of SAH, supporting reproducible mechanistic studies of acute brain injury and delayed vasospasm. This model addresses a key gap in the discovery pipeline by providing a robust platform for evaluating pathophysiological mechanisms and potential interventions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables interrogation of neurovascular injury mechanisms under controlled ICP conditions.
- Supports functional validation of targets implicated in early brain injury and vasospasm.
- Facilitates mechanistic de-risking by isolating acute and delayed SAH effects.
Screening & Assay Development
- Provides a reproducible in vivo system for quantitative monitoring of ICP and cerebral blood flow.
- Standardizes induction of SAH for consistent assay outputs across studies.
- Enables downstream evaluation of candidate therapeutics targeting neurovascular sequelae.
Translational & Preclinical Research
- Aligns with disease-relevant endpoints such as delayed vasospasm and early brain injury.
- Supports continuity from mechanistic discovery to preclinical validation of neuroprotective strategies.
- Enables risk-adjusted advancement decisions based on translationally relevant biomarkers.
Pipeline & Workflow Integration
This model integrates into the discovery-to-preclinical continuum by enabling hypothesis-driven studies of SAH pathophysiology and intervention testing.
- Discovery Biology: Facilitates hypothesis testing on the roles of ICP and blood flow in neurovascular injury.
- Screening: Provides standardized, quantitative readouts for cross-study comparison.
- Analytics: Enables measurement of ICP, cerebral blood flow, and cardiorespiratory parameters for robust data analysis.
- Translational Research: Bridges mechanistic findings to preclinical endpoints relevant to human SAH.
- Enterprise Reuse: Offers a scalable, examiner-independent platform for repeated studies and protocol adaptation.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in neurovascular target validation and mechanistic de-risking.
- Operational Value: Enhances reproducibility and standardization of SAH induction and monitoring.
- Strategic Value: Improves go/no-go decision-making for neurovascular portfolios by reducing biological ambiguity.
- Portfolio Impact: Supports risk-adjusted prioritization of neuroprotective and vasospasm-modulating candidates.
Implementation Considerations
- Requires expertise in vascular surgery and neuromonitoring in small animal models.
- Demands access to digital subtraction angiography and ICP monitoring infrastructure.
- Necessitates rigorous cross-team standardization of surgical and monitoring protocols.
- Adaptation to other species or injury models may require protocol optimization.
- Mortality and morbidity rates must be managed through technical proficiency and perioperative care.
Biopharma FAQs
Chapters in this video
0:05
Title
1:18
Subclavian Artery Cannulation
3:15
Baseline Digital Subtraction Angiography
3:48
Installation of Intracranial Pressure and Cerebral Blood Flow Monitoring
5:55
Shunt Induction
7:32
Results: Representative Subarachnoid Hemorrhage (SAH) Analyses
8:34
Conclusion
